AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26993372 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate ibudilast (40 mg)
Number of subjects: 11
Study 26993372 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ibudilast (100 mg)
Number of subjects: 11
Study 26993372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 25233662 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency acupoint electrical stimulation at Ciliao (BL 32) and Shenshu (BL 23), disperse‐densewave, 2 Hz/100 Hz for 15 to 20 min.
Number of subjects: 90
Study 25233662 — intervention group
Group type: COMPARATOR
Intervention: Intravenous anesthesia of propofol.
Number of subjects: 90
Study 21893345 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA) insertion
Number of subjects: 96
Study 21893345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation with the Macintosh blade
Number of subjects: 96
Study 21893345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation with a videolaryngoscope (GlideScope)
Number of subjects: 96
Study 21893345 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of dental trauma
Number of subjects: 96
Study 23163191 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPCV) administered at ages 0, 1, and 2 months or at 1, 2, and 3 months
Number of subjects: 318
Study 23163191 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 318
Study 23163191 — intervention group
Group type: EXPERIMENTAL
Intervention: Community engagement and strong research partnership
Number of subjects: 318
Study 17343999 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissolution test using paddle, 900ml of medium containing water with 0.7% (w/v) sodium lauryl sulfate at a rotation speed of 25rpm
Number of subjects: 0
Study 17343999 — intervention group
Group type: EXPERIMENTAL
Intervention: HPLC method for dissolution test
Number of subjects: 0
Study 16617617 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality visual stimulation combined with force platform posturography
Number of subjects: 110
Study 16617617 — intervention group
Group type: EXPERIMENTAL
Intervention: Series of tests with different visual and mechanical stimuli
Number of subjects: 110
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: BMIPP uptake in DCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: BMIPP washout in DCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: BMIPP uptake in HCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: BMIPP washout in HCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: Global BMIPP parameters correlation with LVEF in DCM and HCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: Global BMIPP parameters correlation with H/M-TF in DCM and HCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: Early H/M as a predictor for H/M-TF in DCM and HCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional BMIPP parameters correlation with regional function in DCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional BMIPP parameters correlation with regional perfusion in DCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional BMIPP parameters correlation with regional function in HCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional BMIPP parameters correlation with regional perfusion in HCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed regional BMIPP uptake in HCM
Number of subjects: 39
Study 14651352 — intervention group
Group type: EXPERIMENTAL
Intervention: Early regional BMIPP uptake in DCM and HCM
Number of subjects: 39
Study 10480773 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlangen micro lightguide spectrophotometer (EMPHO II) measuring SaO2
Number of subjects: 14
Study 10480773 — intervention group
Group type: COMPARATOR
Intervention: Control sites (not specified)
Number of subjects: 14
Study 10480773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulcers that did not heal
Number of subjects: 14
Study 8857017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac troponin I levels of at least 0.4 ng/mL
Number of subjects: 1404
Study 8857017 — intervention group
Group type: COMPARATOR
Intervention: Cardiac troponin I levels below 0.4 ng/mL
Number of subjects: 1404
Study 8857017 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase of 1 ng/mL in cardiac troponin I level
Number of subjects: 1404
Study 1764383 — intervention group
Group type: EXPERIMENTAL
Intervention: Early stage protocol (adjuvant therapy)
Number of subjects: 481
Study 1764383 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced stages protocol (chemotherapy treatment)
Number of subjects: 481
Study 6846738 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide treatment for 1 week
Number of subjects: 14
Study 6846738 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 1 week
Number of subjects: 14
Study 31487573 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) delivered as therapist-guided bibliotherapy
Number of subjects: 61
Study 28887626 — intervention group
Group type: EXPERIMENTAL
Intervention: Punishment in 100% of adaptation trials
Number of subjects: 0
Study 28887626 — intervention group
Group type: EXPERIMENTAL
Intervention: Reward in 100% of adaptation trials
Number of subjects: 0
Study 28887626 — intervention group
Group type: EXPERIMENTAL
Intervention: Punishment in 50% of adaptation trials (randomly selected)
Number of subjects: 0
Study 25377567 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine in combination with artesunate
Number of subjects: 67
Study 24342543 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous heart rate and respiration rate monitoring in the intervention unit postimplementation.
Number of subjects: 7643
Study 24342543 — intervention group
Group type: COMPARATOR
Intervention: Control unit (no continuous monitoring).
Number of subjects: 7643
Study 21982325 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based exercise program (12 weeks, twice weekly)
Number of subjects: 39
Study 21982325 — intervention group
Group type: COMPARATOR
Intervention: Time-matched computer training program (control group)
Number of subjects: 39
Study 19233760 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-clamp technique (DCT)
Number of subjects: 890
Study 19233760 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-clamp technique (SCT)
Number of subjects: 890
Study 19233760 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump technique
Number of subjects: 890
Study 19233760 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump cross-clamp off technique
Number of subjects: 890
Study 19233760 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 890
Study 17725246 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine, 0.6 mg/day
Number of subjects: 98
Study 17725246 — intervention group
Group type: COMPARATOR
Intervention: Atenolol, 50 mg/day
Number of subjects: 98
Study 15077101 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg
Number of subjects: 3140
Study 15077101 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg
Number of subjects: 3140
Study 11717602 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 0
Study 11717602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9153445 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (mean dose 381 mg/day)
Number of subjects: 32
Study 9153445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 7895790 — intervention group
Group type: EXPERIMENTAL
Intervention: Optokinetic (OK) stimulation rehabilitation program
Number of subjects: 0
Study 7895790 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic posturography (Equitest) measurements
Number of subjects: 0
Study 2949197 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 430
Study 2949197 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (nonaerobic recreational games or no exercise)
Number of subjects: 430
Study 2949197 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-endorphin levels
Number of subjects: 430
Study 30683124 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling (DN) with a self‐stretching home program
Number of subjects: 94
Study 30683124 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Needle Electrolysis (PNE) with a self‐stretching home program
Number of subjects: 94
Study 30115258 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-based general anaesthesia
Number of subjects: 392
Study 30115258 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane-based general anaesthesia
Number of subjects: 392
Study 27039035 — intervention group
Group type: EXPERIMENTAL
Intervention: ayahuasca (0.75mg DMT/kg body weight)
Number of subjects: 12
Study 27039035 — intervention group
Group type: EXPERIMENTAL
Intervention: ketanserin (40mg) + ayahuasca (0.75mg DMT/kg body weight)
Number of subjects: 12
Study 27039035 — intervention group
Group type: COMPARATOR
Intervention: placebo + ayahuasca (0.75mg DMT/kg body weight)
Number of subjects: 12
Study 27039035 — intervention group
Group type: COMPARATOR
Intervention: ketanserin (40mg) + placebo
Number of subjects: 12
Study 27039035 — intervention group
Group type: COMPARATOR
Intervention: placebo + placebo
Number of subjects: 12
Study 24612502 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (2000 mg/day) plus letrozole (2.5 mg/day)
Number of subjects: 104
Study 24612502 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus letrozole (2.5 mg/day)
Number of subjects: 104
Study 23808868 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine use (<30 days abstinence)
Number of subjects: 165
Study 23808868 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine use
Number of subjects: 165
Study 21072738 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration training (WBVT)
Number of subjects: 38
Study 21072738 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study 19009170 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 22
Study 19009170 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval Training (IT)
Number of subjects: 22
Study 19009170 — intervention group
Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 22
Study 16303837 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant hGH treatment (0.1 or 0.2 IU/kg.d)
Number of subjects: 60
Study 16303837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 15094704 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 25 mg/day
Number of subjects: 27
Study 15094704 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 27
Study 11095060 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ACD
Number of subjects: 117
Study 11095060 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with LCD type 1 (LCD1)
Number of subjects: 117
Study 11095060 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with atypical LCDI
Number of subjects: 117
Study 11095060 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with LCD with opacities deep in stroma
Number of subjects: 117
Study 11095060 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with GCD
Number of subjects: 117
Study 11095060 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RBCD
Number of subjects: 117
Study 11095060 — intervention group
Group type: COMPARATOR
Intervention: Normal volunteers (control group)
Number of subjects: 117
Study 8931531 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (3 to 4 sets of 8 to 10 repetitions with a load of 60% to 75% of the subjects' 1‐repetition maximum)
Number of subjects: 42
Study 8931531 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (track walking and step aerobics at an intensity of 50% to 80% of maximum heart‐rate reserve)
Number of subjects: 42
Study 8931531 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 42
Study 1349491 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 100 micrograms
Number of subjects: 10
Study 1349491 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 200 micrograms
Number of subjects: 10
Study 1349491 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 400 micrograms
Number of subjects: 10
Study 1349491 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 400 micrograms
Number of subjects: 10
Study 1349491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6269418 — intervention group
Group type: EXPERIMENTAL
Intervention: High fiber diet (fruits and vegetables)
Number of subjects: 12
Study 6269418 — intervention group
Group type: COMPARATOR
Intervention: Low fiber diet (fruit and vegetable juices)
Number of subjects: 12
Study 30689513 — intervention group
Group type: EXPERIMENTAL
Intervention: MOTR+GPM‐BV
Number of subjects: 60
Study 30689513 — intervention group
Group type: COMPARATOR
Intervention: GPM‐BV
Number of subjects: 60
Study 30894146 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial unicondylar knee arthroplasty (mUKA)
Number of subjects: 350
Study 30894146 — intervention group
Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 350
Study 29092886 — intervention group
Group type: EXPERIMENTAL
Intervention: 2RDA (1.6 g protein · kg‐1 · d‐1)
Number of subjects: 29
Study 29092886 — intervention group
Group type: COMPARATOR
Intervention: RDA (0.8 g protein · kg‐1 · d‐1)
Number of subjects: 29
Study 25775249 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged sedentary time (30 min/day less) and light-intensity activity (30 min/day more)
Number of subjects: 279
Study 25775249 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged sedentary time (30 min/day less) and non-prolonged sedentary time (30 min/day more)
Number of subjects: 279
Study 25775249 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged sedentary time (30 min/day less) and light-intensity time (30 min/day more)
Number of subjects: 279
Study 25775249 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-intensity activity
Number of subjects: 279
Study 23806736 — intervention group
Group type: EXPERIMENTAL
Intervention: α-cyclodextrin (2 g)
Number of subjects: 0
Study 23806736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21729265 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management program in addition to diabetes management program
Number of subjects: 230
Study 21729265 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual from general practitioner and other care providers
Number of subjects: 230
Study 19297572 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV vaccine (recombinant CMV envelope glycoprotein B with MF59 adjuvant)
Number of subjects: 464
Study 19297572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 464
Study 19297572 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV vaccine
Number of subjects: 464
Study 18085104 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced anesthesia (group A)
Number of subjects: 60
Study 18085104 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil‐based anesthesia and analgesia (group B)
Number of subjects: 60
Study 18085104 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined general‐epidural anesthesia (group C)
Number of subjects: 60
Study 17144474 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaozheng pills
Number of subjects: 240
Study 17144474 — intervention group
Group type: COMPARATOR
Intervention: Rujiekang mimetic (placebo)
Number of subjects: 240
Study 17144474 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (trial and control)
Number of subjects: 240
Study 12886586 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of essentiale and T‐activin
Number of subjects: 117
Study 10591235 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (100 microg subcutaneously)
Number of subjects: 19
Study 10591235 — intervention group
Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 19
Study 8764668 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (0.25 mg/kg)
Number of subjects: 8
Study 8764668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1941060 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesna
Number of subjects: 100
Study 1941060 — intervention group
Group type: COMPARATOR
Intervention: Hyperhydration (forced saline diuresis)
Number of subjects: 100
Study 7200210 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen (Premarin, 2.5 mg per day)
Number of subjects: 29
Study 29356022 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical treatment with corrective lenses based on cycloplegic refraction for amblyopia
Number of subjects: 80
Study 29356022 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical treatment
Number of subjects: 80
Study 26165528 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-rebreather mask (NRB) at 15 L·min⁻¹
Number of subjects: 15
Study 26165528 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-rebreather mask (NRB) at 10 L·min⁻¹
Number of subjects: 15
Study 26165528 — intervention group
Group type: EXPERIMENTAL
Intervention: Demand valve with oronasal mask
Number of subjects: 15
Study 26165528 — intervention group
Group type: COMPARATOR
Intervention: Oxygen 'head hood' (reference standard)
Number of subjects: 15
Study 23188416 — intervention group
Group type: EXPERIMENTAL
Intervention: Omron HEM‐9000AI
Number of subjects: 33
Study 23188416 — intervention group
Group type: EXPERIMENTAL
Intervention: SphygmoCor
Number of subjects: 33
Study 21961941 — intervention group
Group type: EXPERIMENTAL
Intervention: Anidulafungin
Number of subjects: 135
Study 21961941 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 135
Study 18182467 — intervention group
Group type: EXPERIMENTAL
Intervention: PE + F (oral fludrocortisone, 0.2 mg)
Number of subjects: 69
Study 18182467 — intervention group
Group type: EXPERIMENTAL
Intervention: PE + D (oral dexamethasone, 0.75 mg)
Number of subjects: 69
Study 18182467 — intervention group
Group type: EXPERIMENTAL
Intervention: PE + F + D (both type I and type II agonists)
Number of subjects: 69
Study 18182467 — intervention group
Group type: COMPARATOR
Intervention: PE (hyperinsulinemic euglycemic clamp)
Number of subjects: 69
Study 18182467 — intervention group
Group type: COMPARATOR
Intervention: PH (hypoglycemic clamp)
Number of subjects: 69
Study 15832428 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 80
Study 15832428 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 80
Study 12855334 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection (5 microg in 0.2 ml) into the masseter muscle
Number of subjects: 0
Study 12855334 — intervention group
Group type: COMPARATOR
Intervention: Buffered isotonic saline injection into the masseter muscle
Number of subjects: 0
Study 12855334 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-injected temporalis muscles
Number of subjects: 0
Study 10513162 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin
Number of subjects: 22
Study 10513162 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 22
Study 8708517 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valerate 2 mg/day for 21 days and Norgestrel 0.5 mg/day from day 12 to 21 for the first 8 weeks, followed by placebo for the last 8 weeks
Number of subjects: 60
Study 8708517 — intervention group
Group type: COMPARATOR
Intervention: Placebo for the first 8 weeks, followed by Estradiol valerate and Norgestrel for the last 8 weeks
Number of subjects: 60
Study 1931064 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 99
Study 1931064 — intervention group
Group type: COMPARATOR
Intervention: Thiopental sodium-isoflurane anesthesia
Number of subjects: 99
Study 6814471 — intervention group
Group type: EXPERIMENTAL
Intervention: BHT 933 (5 mg)
Number of subjects: 12
Study 6814471 — intervention group
Group type: EXPERIMENTAL
Intervention: BHT 933 (10 mg)
Number of subjects: 12
Study 31709640 — intervention group
Group type: EXPERIMENTAL
Intervention: Disaster nursing preparedness training program (7 hours)
Number of subjects: 63
Study 31709640 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 63
Study 31709640 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study 30636436 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB messages
Number of subjects: 407
Study 30636436 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intentions to avoid binge drinking
Number of subjects: 407
Study 30636436 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TPB messages)
Number of subjects: 407
Study 30636436 — intervention group
Group type: COMPARATOR
Intervention: Control group (no implementation intentions)
Number of subjects: 407
Study 28542675 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of intravenous acetaminophen (IVAPAP)
Number of subjects: 62
Study 28542675 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 mL saline infusion)
Number of subjects: 62
Study 28542675 — intervention group
Group type: EXPERIMENTAL
Intervention: IVAPAP
Number of subjects: 62
Study 28542675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 26075174 — intervention group
Group type: EXPERIMENTAL
Intervention: Underlay technique
Number of subjects: 114
Study 26075174 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-underlay technique
Number of subjects: 114
Study 23343675 — intervention group
Group type: EXPERIMENTAL
Intervention: Bing sweet cherries (280 g/d) for 28 days
Number of subjects: 18
Study 21084270 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (2 g/d)
Number of subjects: 92